You haven't searched anything yet.
Harmony Biosciences is recruiting for a Manager, Medical Affairs Operations our Plymouth meeting, PA location. In this role you will be responsible for supporting the Medical Affairs Operations function through vendor management, budgeting, and project management for the department based on the Medical Affairs strategy. This role will prioritize and prepare project plans, ensure visibility across all key projects, manage project budgets, and ensure timelines and deliverables are achieved.
Responsibilities include but are not limited to:
Qualifications:
Physical demands and work environment:
What can Harmony offer you?
Want to see our latest job opportunities? Follow us on !
Harmony Biosciences is a pharmaceutical company headquartered in Plymouth Meeting, PA. The company was established in October 2017 with a vision to provide novel treatment options for people living with rare, neurological disorders who have unmet medical needs. For more information on Harmony Biosciences, visit
Harmony Biosciences, LLC is an Equal Opportunity, e-Verify Employer. All qualified applicants will receive equal consideration for employment without regard to race, color, national origin, religion, sex, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class.
Recruitment agencies please note: Harmony Biosciences will only accept applications from agencies/business partners that have been invited to work on a specific role. Candidate Resumes/CV's submitted without permission or directly to Hiring Managers will be considered unsolicited and no fee will be payable. Thank you for your cooperation.
Full Time
Pharmaceutical
$117k-158k (estimate)
03/15/2024
05/14/2024
harmonybiosciences.com
PLYMOUTH MEETING, PA
100 - 200
2017
Public
JOHN JACOBS
$5M - $10M
Pharmaceutical
Harmony Biosciences is a biopharmaceutical company that researches and develops novel therapeutics for patients with orphan and rare diseases.